Related Experiment Video
Updated: Mar 27, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
Published on: July 15, 2011
Leprosy in Denmark 1980-2010: a review of 15 cases
Huma Aftab1,2, Susanne D Nielsen3, Ib C Bygbjerg4,5
1Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Denmark. humaftab@dadlnet.dk.
Background:
Leprosy, caused by Mycobacterium leprae, is a chronic and progressive granulomatous disease affecting mainly the skin and the peripheral nervous system. If left unrecognized, the infection can lead to permanent nerve damage and disability. The clinical presentation depends on the immune response of the patient and can result in a wide spectrum of symptoms. Leprosy is a rare encounter in Scandinavia but remains endemic in some parts of the world, with some areas reporting an increasing incidence. We performed a retrospective record review of leprosy cases in Denmark from 1980 to 2010 with the purpose of presenting the most common geographical, demographic and clinical findings and to discuss the diagnostic and therapeutic challenges of patients with leprosy.
Case Presentation:
In total 15 cases were reviewed. The majority (87%) of leprosy patients in Denmark were born in South- and Southeast Asia, and were presumed to have contracted the infection in their countries of origin. Patients were predominately young males (mean age: 28.6 years). Anaesthetic skin lesion with or without nerve enlargement were the most common clinical presentations (73%). Immunological leprosy reactions were seen in 40% of the cases. Diagnoses were based on clinical findings and skin biopsies. Treatment length varied but all patients received multidrug regimens.
Conclusion:
Leprosy should be kept in mind when encountering patients with suspicious skin lesions originating from leprosy endemic areas or with history of travel or work in the tropics. Due to the long incubation period with symptoms presenting long after immigration or return, clinicians often do not have the diagnosis in mind. The wide spectrum of symptoms and immunological reactions further complicates the diagnostic process. Treatment of leprosy and the complicated immunological reactions, which frequently accompanies the infection, should be performed in collaboration with a specialist.
Insights
Leprosy (caused by Mycobacterium leprae) is rare in Denmark but often affects immigrants. Early diagnosis and specialist collaboration are key for managing this chronic skin and nerve disease.
Area of Science:
- Infectious Diseases
- Dermatology
- Neurology
Background:
- Leprosy (caused by Mycobacterium leprae) is a chronic granulomatous disease impacting skin and peripheral nerves.
- Delayed recognition can lead to irreversible nerve damage and disability.
- Clinical presentation varies widely based on patient immune response.
Purpose of the Study:
- To review leprosy cases in Denmark (1980-2010).
- To identify common geographical, demographic, and clinical findings.
- To discuss diagnostic and therapeutic challenges.
Main Methods:
- Retrospective record review of 15 leprosy cases.
- Analysis of patient origin, age, clinical presentation, and treatment.
- Diagnosis based on clinical findings and skin biopsies.
Main Results:
- 87% of patients were from South/Southeast Asia, likely infected in their origin countries.
- Young males (mean age 28.6) predominated.
- Anesthetic skin lesions with nerve enlargement were common (73%); 40% experienced reactions.
Conclusions:
- Consider leprosy in patients with suspicious skin lesions from endemic areas or tropical travel history.
- Long incubation periods and varied symptoms complicate diagnosis.
- Management of leprosy and its reactions requires specialist collaboration.
More Related Videos
10:32Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
10:37Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
Published on: November 25, 2022
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Investigation of Disease Outbreaks
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infectious Diseases and Their Occurrence
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...